Cliftonlarsonallen Wealth Advisors, LLC Organon & Co. Transaction History

Cliftonlarsonallen Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$31.66 - $38.9 $95,423 - $117,244	-3,014 Reduced 18.96%	12,885 $435,000
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $2,892 - $3,739	-95 Reduced 0.59%	15,899 $555,000
Q4 2021 Jan 26, 2022	SELL	$28.67 - $37.13 $3,354 - $4,344	-117 Reduced 0.73%	15,994 $487,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $461,257 - $574,196	16,111 New	16,111 $528,000
Q3 2021 Oct 14, 2021	SELL	$28.63 - $35.64 $376,713 - $468,951	-13,158 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$28.45 - $38.0 $374,345 - $500,004	13,158 New	13,158 $398,000

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cliftonlarsonallen Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cliftonlarsonallen Wealth Advisors, LLC with notifications on news.